It’s the things a young child doesn’t do that may give the clues to the presence of Autism. Because early symptoms of Autism are often characterised by an absence of normal behavioural development rather than the presence of unusual behaviour, diagnosis and early intervention can be crucially delayed.
In an effort to find a better therapy and improve the lives of people with epilepsy, the Massachusetts General Hospital (MGH) Epilepsy Service is participating in the RNS? System Pivotal Clinical Investigation, a study to evaluate the safety and effectiveness of a responsive brain stimulation device in reducing the frequency of uncontrolled seizures. MGH is one of only 28 centers across the country participating in this study.
Two new large-scale genomic studies have honed in on the main genetic pathway associated with multiple sclerosis, while also uncovering new genetic variations in the disease and suggesting a possible link between multiple sclerosis and other autoimmune diseases.
For every man with a migraine, three women are struck by the severe headaches that often come with nausea, sensitivity to light and sound, and aura. That means a staggering 18 to 25 percent of women suffer from migraines, making it one of the most common disabling conditions faced by women around the globe.
One of six Autism Centers of Excellence (ACE) in the country has been established at the University of California, San Diego by the National Institutes of Health (NIH), to be directed by Eric Courchesne, Ph.D., professor of neurosciences at the UC San Diego School of Medicine and a leading expert on brain abnormalities associated with autism, a brain disorder affecting an estimated two million people in the U.S. The symptoms are impaired social, emotional, language and cognitive development.
UK Health dept intends to re-open negotiations about the current Pharmaceutical Price Regulation Scheme (PPRS). A UK Dept of Health spokesperson said
Patients treated with Betaferon? (interferon beta-1b) shortly after their first clinical MS event or ?attack? showed a 40 percent lower risk of developing confirmed disability when compared to patients in whom treatment was delayed. The results ? which were fast-tracked and published in The Lancet today ? provide the first controlled evidence that delaying Betaferon? treatment has an effect on later accumulation of disability. No other MS therapy has demonstrated this effect in this early patient population.
Following a joint meeting of the US Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development underscores its position that ACTOS (pioglitazone HCl) offers a proven safety profile regarding the risk of cardiovascular disease.
A preliminary study of 85 patients with bipolar disorder shows that a drug used to treat patients with sleep disorders might also control the depressive symptoms associated with bipolar disorder. At least 44 percent of the participants in the study reported improved symptoms, a noteworthy improvement for a disorder in which new treatments are needed, according to the study’s author, Mark Frye, M.D., director of the Mayo Clinic Mood Disorders Clinic and Research Program.
Mayo Clinic is launching a series of new free audio podcasts so people can learn more about diseases or conditions that interest them through in-depth discussions with Mayo Clinic experts.